Literature DB >> 8433072

Elevated level of erythropoietin in congestive heart failure relationship to renal perfusion and plasma renin.

J D Jensen1, H Eiskjaer, J P Bagger, E B Pedersen.   

Abstract

BACKGROUND: In animal experiments reduction of renal perfusion can stimulate erythropoietin production. The relationship between renal haemodynamics and erythropoietin production is unknown in congestive heart failure.
OBJECTIVE: The aim was to study the relationship between serum erythropoietin and renal haemodynamics, plasma renin activity and haematocrit in patients with congestive heart failure and in healthy control subjects. PATIENTS AND METHODS: Serum erythropoietin, renal plasma flow, glomerular filtration rate and plasma renin activity were determined in 14 patients with acyanotic congestive heart failure, and 36 healthy controls.
RESULTS: Serum erythropoietin was significantly elevated in congestive heart failure 26.6 U l-1 (median) compared with controls 17.0 U l-1 despite a normal haematocrit, and increased with the severity of congestive heart failure (New York Heart Association class II: 17 U l-1 [n = 4]; class III: 30 U l-1 [n = 5]; class IV: 45 U l-1 [n = 5]). Significant inverse correlations between serum erythropoietin and renal plasma flow (r = -0.60, P < 0.03), and between serum erythropoietin and glomerular filtration rate, were found in congestive heart failure but not in the control subjects. A significant positive correlation (r = 0.71, P < 0.03) was demonstrated between serum erythropoietin and plasma renin activity in congestive heart failure.
CONCLUSION: A severe reduction in renal perfusion in congestive heart failure appears to cause an increase in serum erythropoietin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433072     DOI: 10.1111/j.1365-2796.1993.tb00664.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  Anaemia and heart failure.

Authors:  A J S Coats
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.

Authors:  J Cole; D Ertoy; H Lin; R L Sutliff; E Ezan; T T Guyene; M Capecchi; P Corvol; K E Bernstein
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Darbepoetin-alpha prevents progressive left ventricular dysfunction and remodeling in nonanemic dogs with heart failure.

Authors:  Sharad Rastogi; Makoto Imai; Victor G Sharov; Sudhish Mishra; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

Review 4.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

Review 5.  Heart failure and anemia: mechanisms and pathophysiology.

Authors:  Inder S Anand
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

Review 6.  Antihypertensive medications and anemia.

Authors:  Domenic A Sica; Rosemarie Mannino
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-09       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.